These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11388887)

  • 1. Reversible renal impairment induced by treatment with the angiotensin II receptor antagonist candesartan in a patient with bilateral renal artery stenosis.
    Johansen TL; Kjaer A
    BMC Nephrol; 2001 May; 2():1. PubMed ID: 11388887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Change from ACE inhibitor, Ca-antagonist or beta-blocker to candesartan cilexetil: better efficacy and tolerance. SWITCH study (German study segment)].
    Baumgart P; Reismann J; Pohlmeyer H; Düsing R
    Dtsch Med Wochenschr; 2001 May; 126(19):547-50. PubMed ID: 11402910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan associated with acute renal failure in a patient with bilateral renal artery stenosis.
    Bavbek N; Kasapoglu B; Isik A; Kargili A; Kirbas I; Akcay A
    Ren Fail; 2010; 32(9):1115-7. PubMed ID: 20863218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of candesartan cilexetil (the new angiotensin II antagonist) on systemic and renal haemodynamics in hypertensive patients.
    Fridman K; Andersson OK; Wysocki M; Friberg P; Sunzel M
    Eur J Clin Pharmacol; 1998 Sep; 54(7):497-501. PubMed ID: 9832289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Angiotensin II antagonist treatment as a contributory cause of acute renal failure].
    Nielsen LR
    Ugeskr Laeger; 2003 Mar; 165(13):1368-9. PubMed ID: 12703286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversible acute renal failure induced by losartan in a renal transplant recipient.
    Ostermann M; Goldsmith DJ; Doyle T; Kingswood JC; Sharpstone P
    Postgrad Med J; 1997 Feb; 73(856):105-7. PubMed ID: 9122087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bilateral renal artery stenosis--a cause of acute pulmonary edema].
    Høieggen A; Draganov B; Os I
    Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1789-90. PubMed ID: 11464682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute renal failure secondary to angiotensin II receptor blockade in a patient with bilateral renal artery stenosis.
    Wargo KA; Chong K; Chan EC
    Pharmacotherapy; 2003 Sep; 23(9):1199-204. PubMed ID: 14524653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized trial of candesartan cilexetil in the treatment of patients with congestive heart failure and a history of intolerance to angiotensin-converting enzyme inhibitors.
    Granger CB; Ertl G; Kuch J; Maggioni AP; McMurray J; Rouleau JL; Stevenson LW; Swedberg K; Young J; Yusuf S; Califf RM; Bart BA; Held P; Michelson EL; Sellers MA; Ohlin G; Sparapani R; Pfeffer MA
    Am Heart J; 2000 Apr; 139(4):609-17. PubMed ID: 10740141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin converting enzyme inhibition in renovascular hypertension.
    Burnier M; Waeber B; Nussberger J; Brunner HR
    J Hypertens Suppl; 1989 Sep; 7(7):S27-31. PubMed ID: 2693654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candesartan cilexetil induced pustular psoriasis.
    Kawamura A; Ochiai T
    Eur J Dermatol; 2003; 13(4):406-7. PubMed ID: 12948927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acute renal failure, renal artery stenosis and angiotensin-converting enzyme (ACE) inhibitor].
    Svarstad E; Hultstrøm D; Jensen D; Jenssen G; Gravendeel J; Iversen BM
    Tidsskr Nor Laegeforen; 2001 Jun; 121(15):1784-8. PubMed ID: 11464681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal artery stenosis and peripheral vascular disease: implications for ACE inhibitor therapy.
    Salmon P; Brown MA
    Lancet; 1990 Aug; 336(8710):321. PubMed ID: 1974015
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of candesartan cilexetil and enalapril on inflammatory markers of atherosclerosis in hypertensive patients with non-insulin-dependent diabetes mellitus.
    Rosei EA; Rizzoni D; Muiesan ML; Sleiman I; Salvetti M; Monteduro C; Porteri E;
    J Hypertens; 2005 Feb; 23(2):435-44. PubMed ID: 15662233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema multiforme associated with candesartan cilexetil.
    Ejaz AA; Walsh JS; Wasiluk A
    South Med J; 2004 Jun; 97(6):614-5. PubMed ID: 15255435
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Candesartan cilexetil--a review of effects on cardiovascular complications in hypertension and chronic heart failure.
    Meredith PA
    Curr Med Res Opin; 2007 Jul; 23(7):1693-705. PubMed ID: 17588300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cross reactivity between ACE inhibitors and angiotensin receptor blockers].
    Rosenborg S
    Lakartidningen; 2010 Feb 17-23; 107(7):444. PubMed ID: 20384078
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of dual blockade of the renin-angiotensin system in primary proteinuric nephropathies.
    Luño J; Barrio V; Goicoechea MA; González C; de Vinuesa SG; Gómez F; Bernis C; Espinosa M; Ahijado F; Gómez J; Escalada P
    Kidney Int Suppl; 2002 Dec; (82):S47-52. PubMed ID: 12410855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candesartan improves blood pressure control and reduces proteinuria in renal transplant recipients: results from SECRET.
    Philipp T; Martinez F; Geiger H; Moulin B; Mourad G; Schmieder R; Lièvre M; Heemann U; Legendre C
    Nephrol Dial Transplant; 2010 Mar; 25(3):967-76. PubMed ID: 19887503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.